Package 64980-206-12

{"route": ["ORAL"], "spl_id": "984587a3-4875-4ad3-af6e-11b90fe705a8", "openfda": {"nui": ["N0000175956", "N0000175955", "N0000008683"], "unii": ["V1L22WVE2S"], "rxcui": ["730834"], "spl_set_id": ["fd382540-b390-4e86-a94a-988ea89c93a8"], "pharm_class_pe": ["Decreased Leukotriene Production [PE]"], "pharm_class_epc": ["5-Lipoxygenase Inhibitor [EPC]"], "pharm_class_moa": ["5-Lipoxygenase Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-206-12)", "package_ndc": "64980-206-12", "marketing_start_date": "20170321"}], "brand_name": "Zileuton", "product_id": "64980-206_984587a3-4875-4ad3-af6e-11b90fe705a8", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["5-Lipoxygenase Inhibitor [EPC]", "5-Lipoxygenase Inhibitors [MoA]", "Decreased Leukotriene Production [PE]"], "product_ndc": "64980-206", "generic_name": "Zileuton", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zileuton", "active_ingredients": [{"name": "ZILEUTON", "strength": "600 mg/1"}], "application_number": "ANDA204929", "marketing_category": "ANDA", "marketing_start_date": "20170321", "listing_expiration_date": "20261231"}